Quick Answer
Neuronetics, Inc. reported Total Revenue of $149.16 million for fiscal year 2025.
Neuronetics, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $149.16M +99.2% |
$74.89M +5.0% |
$71.35M +9.4% |
$65.21M +17.9% |
$55.31M +12.3% |
$49.24M -21.4% |
| Revenue (ASC 606) | $149.16M +99.2% |
$74.89M +5.0% |
$71.35M +9.4% |
$65.21M +17.9% |
$55.31M +12.3% |
$49.24M -21.4% |
| Net Income | -$39.00M +10.8% |
-$43.71M -44.8% |
-$30.19M +18.8% |
-$37.16M -19.1% |
-$31.19M -13.6% |
-$27.45M +5.5% |
| Diluted EPS | -$0.59 +57.2% |
-$1.38 -31.4% |
-$1.05 +23.9% |
-$1.38 -13.1% |
-$1.22 +16.4% |
-$1.46 +7.6% |
| Total Assets | $141.55M +0.5% |
$140.90M +21.6% |
$115.83M -0.9% |
$116.88M -17.2% |
$141.22M +79.5% |
$78.66M -21.5% |
| Cash and Equivalents | $28.13M +52.4% |
$18.46M -69.1% |
$59.68M -15.2% |
$70.34M -25.3% |
$94.14M +92.3% |
$48.96M -35.3% |
| Long-Term Debt | $65.81M +19.3% |
$55.15M -7.0% |
$59.28M +159.7% |
$22.83M -35.4% |
$35.34M +2.1% |
$34.62M +74.0% |
| Stockholders Equity | $22.38M -19.2% |
$27.71M -19.0% |
$34.19M -40.1% |
$57.06M -33.0% |
$85.17M +234.1% |
$25.49M -46.7% |
| R&D Expense | $6.58M -48.4% |
$12.77M +34.2% |
$9.52M +1.9% |
$9.34M +17.8% |
$7.92M -13.9% |
$9.20M -33.1% |
| Operating Income | -$31.44M +9.0% |
-$34.56M -13.1% |
-$30.55M +13.0% |
-$35.11M -27.4% |
-$27.56M -23.6% |
-$22.31M +17.2% |
| Gross Profit | $72.31M +33.5% |
$54.16M +4.8% |
$51.70M +4.0% |
$49.72M +13.9% |
$43.66M +15.8% |
$37.69M -20.3% |
| Shares Outstanding | 68.99M +23.9% |
55.68M +91.4% |
29.09M +6.7% |
27.27M +3.3% |
26.39M +38.1% |
19.11M +2.5% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $37.30M | +101.3% | -2.1% |
| Revenue (ASC 606) | September 30, 2025 | $37.30M | +101.3% | -2.1% |
| Net Income | September 30, 2025 | -$9.04M | +32.2% | +10.6% |
| Diluted EPS | September 30, 2025 | -$0.13 | +70.5% | +13.3% |
| Total Assets | September 30, 2025 | $145.47M | +96.3% | +8.0% |
| Cash and Equivalents | September 30, 2025 | $27.97M | +34.0% | +155.0% |
| Long-Term Debt | September 30, 2025 | $65.67M | +42.8% | +18.2% |
| Stockholders Equity | September 30, 2025 | $27.36M | +191.6% | +0.8% |
| R&D Expense | September 30, 2025 | $1.50M | -37.7% | -16.4% |
| Operating Income | September 30, 2025 | -$7.32M | +5.3% | +9.1% |
| Gross Profit | September 30, 2025 | $17.11M | +22.2% | -3.7% |
| Shares Outstanding | September 30, 2025 | 68.44M | +125.8% | +3.5% |
- Neuronetics, Inc. reported Total Revenue of $149.16 million for fiscal year 2025.
- Neuronetics, Inc. showed an increase of +99.2% in Total Revenue compared to the prior fiscal year.
- Neuronetics, Inc. reported Revenue (ASC 606) of $149.16 million for fiscal year 2025.
- Neuronetics, Inc. showed an increase of +99.2% in Revenue (ASC 606) compared to the prior fiscal year.
- Neuronetics, Inc. reported Net Income of -$39.00 million for fiscal year 2025.
- Neuronetics, Inc. showed an increase of +10.8% in Net Income compared to the prior fiscal year.
- Neuronetics, Inc. reported Diluted EPS of $0.59 per share (loss) for fiscal year 2025.
- Neuronetics, Inc. showed an increase of +57.2% in Diluted EPS compared to the prior fiscal year.
- Neuronetics, Inc. reported Total Assets of $141.55 million for fiscal year 2025.
- Neuronetics, Inc. showed an increase of +0.5% in Total Assets compared to the prior fiscal year.
- Neuronetics, Inc. reported Cash and Equivalents of $28.13 million for fiscal year 2025.
- Neuronetics, Inc. showed an increase of +52.4% in Cash and Equivalents compared to the prior fiscal year.
- Neuronetics, Inc. reported Long-Term Debt of $65.81 million for fiscal year 2025.
- Neuronetics, Inc. showed an increase of +19.3% in Long-Term Debt compared to the prior fiscal year.
- Neuronetics, Inc. reported Stockholders Equity of $22.38 million for fiscal year 2025.
- Neuronetics, Inc. showed a decrease of -19.2% in Stockholders Equity compared to the prior fiscal year.
- Neuronetics, Inc. reported R&D Expense of $6.58 million for fiscal year 2025.
- Neuronetics, Inc. showed a decrease of -48.4% in R&D Expense compared to the prior fiscal year.
- Neuronetics, Inc. reported Operating Income of -$31.44 million for fiscal year 2025.
- Neuronetics, Inc. showed an increase of +9.0% in Operating Income compared to the prior fiscal year.
- Neuronetics, Inc. reported Gross Profit of $72.31 million for fiscal year 2025.
- Neuronetics, Inc. showed an increase of +33.5% in Gross Profit compared to the prior fiscal year.
- Neuronetics, Inc. reported Shares Outstanding of 68.99 million shares for fiscal year 2025.
- Neuronetics, Inc. showed an increase of +23.9% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: